VE-4840, an oral plasma kallikrein inhibitor, decreases human plasma kallikrein and VEGF-induced retinal thickening and vascular permeability
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI